| Literature DB >> 27821053 |
L M Kramer1, M A Abdel Ghaffar2, J E Koltes3, E R Fritz-Waters1, M S Mayes1, A D Sewell4, N T Weeks5, D J Garrick1, R L Fernando1, L Ma6, J M Reecy7.
Abstract
BACKGROUND: Consumers are becoming increasingly conscientious about the nutritional value of their food. Consumption of some fatty acids has been associated with human health traits such as blood pressure and cardiovascular disease. Therefore, it is important to investigate genetic variation in content of fatty acids present in meat. Previously publications reported regions of the cattle genome that are additively associated with variation in fatty acid content. This study evaluated epistatic interactions, which could account for additional genetic variation in fatty acid content.Entities:
Keywords: Beef cattle; Epistatic interaction; Fatty acids; Phospholipid; Triacylglyceride
Mesh:
Substances:
Year: 2016 PMID: 27821053 PMCID: PMC5100273 DOI: 10.1186/s12864-016-3235-8
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
The phenotypic summary statistics for TAG and PL fatty acid traits
| Triacylglycerol Fatty Acids | Phospholipid Fatty Acids | ||||||
|---|---|---|---|---|---|---|---|
| Trait | Mean ( | SD | CV | Trait | Mean ( | SD | CV |
| Saturated Fatty Acids | |||||||
| SFA | 45.8 | 2.5 | 0.05 | SFA | 38.44 | 5.26 | 0.14 |
| 12:0 | 0.13 | 0.19 | 1.46 | 12:0 | 1.4 | 1.8 | 1.28 |
| 14:0 | 3.08 | 0.51 | 0.16 | 14:0 | 3.33 | 4.55 | 1.37 |
| 16:0 | 27.35 | 1.75 | 0.06 | 16:0 | 20.2 | 3.49 | 0.17 |
| 17:0 | 1.42 | 0.39 | 0.28 | 17:0 | 1.75 | 2.6 | 1.48 |
| 18:0 | 13.23 | 1.9 | 0.14 | 18:0 | 9.88 | 2.51 | 0.25 |
| 22:0 | 0.02 | 0.06 | 2.73 | 22:0 | 0.85 | 1.07 | 1.26 |
| 23:0 | 0.01 | 0.06 | 3.84 | 23:0 | 0.17 | 0.43 | 2.47 |
| 24:0 | 0.03 | 0.08 | 2.83 | 24:0 | 0.45 | 0.66 | 1.45 |
| Monounsaturated Fatty Acids | |||||||
| MUFA | 51.57 | 2.56 | 0.05 MUFA | 24.07 | 7.7 | 0.32 | MUFA |
| 14:1 | 0.7 | 0.21 | 0.3 | 14:1 | 0.22 | 0.54 | 2.43 |
| 16:1 | 3.82 | 0.61 | 0.16 | 16:1 | 0.72 | 0.83 | 1.15 |
| 17:1 | 1.01 | 0.33 | 0.32 | 17:1 | 1.21 | 1.02 | 0.84 |
| 18:1 cis-9 | 40.26 | 2.86 | 0.07 | 18:1 cis-9 | 19.31 | 6.71 | 0.35 |
| 18:1 cis-11 | 0.11 | 0.1 | 0.92 | 18:1 cis-11 | 0.08 | 0.3 | 3.91 |
| 18:1 cis-12 | 0.3 | 0.16 | 0.52 | 18:1 cis-12 | 0.04 | 0.35 | 9.22 |
| 18:1 cis-13 | 0.11 | 0.12 | 1.17 | 18:1 cis-13 | 0.09 | 0.51 | 5.97 |
| 18:1, trans-6/9 | 0.19 | 0.45 | 2.4 | 18:1, trans-6/9 | 0.04 | 0.33 | 8.29 |
| 18:1, trans-10/11 | 3.69 | 1.57 | 0.43 | 18:1, trans-10/11 | 0.59 | 1.18 | 2.01 |
| 18:1, trans-12 | 0.18 | 1.15 | 6.21 | 18:1, trans-12 | 0.03 | 0.19 | 6.48 |
| 18:1, trans-15 | 1.15 | 0.36 | 0.31 | 18:1, trans-15 | 1.51 | 1.68 | 1.11 |
| Polyunsaturated Fatty Acids | |||||||
| PUFA | 2.63 | 0.89 | 0.34 | PUFA | 37.49 | 8.72 | 0.23 |
| 18:2 | 2.01 | 0.52 | 0.26 | 18:2 | 25.67 | 6.72 | 0.26 |
| 18:3, n-3 | 0.16 | 0.16 | 0.99 | 18:3, n-3 | 0.12 | 0.71 | 5.85 |
| 20:2 | 0.08 | 0.11 | 1.4 | 20:2 | 0.05 | 0.27 | 5.32 |
| 20:4 | 0.02 | 0.08 | 3.55 | 20:4 | 8.4 | 2.73 | 0.32 |
| 20:5 | 0.1 | 0.16 | 1.68 | 20:5 | 0.37 | 0.56 | 1.51 |
| 22:6 | 0.06 | 0.26 | 4.65 | 22:6 | 0.19 | 0.79 | 4.14 |
| CLA cis-9 trans-11 | 0.04 | 0.09 | 2.08 | CLA cis-9 trans-11 | 0.06 | 0.6 | 10.08 |
| CLA trans-10 cis-12 | 0.12 | 0.12 | 1.03 | CLA trans-10 cis-12 | 0.04 | 0.29 | 6.87 |
| n-3 | 0.33 | 0.4 | 1.22 | n-3 | 2.31 | 2.09 | 0.91 |
| n-6 | 2.3 | 0.63 | 0.28 | n-6 | 35.18 | 8.31 | 0.24 |
| Ratio/Calculation | |||||||
| n-6:n-3 | 0.14 | 0.15 | 1.05 | n-6:n-3 | 0.07 | 0.07 | 1.07 |
| PUFASFA | 0.06 | 0.02 | 0.36 | PUFASFA | 1.01 | 0.31 | 0.31 |
| MCFA | 4.42 | 0.8 | 0.18 | MCFA | 5.21 | 4.01 | 0.77 |
| LCFA | 95.58 | 0.8 | 0.01 | LCFA | 94.79 | 4.01 | 0.04 |
| IAa | 0.74 | 0.09 | 0.12 | IAa | 0.59 | 0.33 | 0.56 |
aIA: Index of Atherogenicity
Mean, Standard Deviation (SD), Coefficient of variation (CV) calculated for all 1,721 and 1,442 head of cattle used to identify significant epistatic interactions in triacylglyceride and phospholipids fatty acid traits respectively
Summary statistics for weight traits (kilograms)
| Trait | Mean ( | SD | CV × 100 |
|---|---|---|---|
| Hot Carcass Weight | 332.48 | 32.66 | 9.82 |
| Yearling Weight | 431.59 | 82.58 | 19.13 |
| Weaning Weight | 184.86 | 42.97 | 23.25 |
Mean, Standard Deviation (SD), Coefficient of variation (CV) calculated for 2,324 head of cattle used to identify significant epistatic interactions for weight traits
Number of significant interactions at 50 and 100 animals per genotype combination filters
| TAG Fatty acid traits | PL Fatty acid traits | ||||||
|---|---|---|---|---|---|---|---|
| Trait | FDR | 50-Animal Filter | 100-Animal Filter | Trait | FDR | 50-Animal Filter | 100-Animal Filter |
| Saturated fatty acids | |||||||
| SFA | 3671 | 249 | 179 | SFA | 2595 | 148 | 117 |
| 12:0 | 9559 | 6 | 5 | 12:0 | 1227 | 39 | 14 |
| 14:0 | 1017 | 835 | 511 | 14:0 | 7 | 7 | 5 |
| 16:0 | 9559 | 0 | 0 | 16:0 | 9563 | 0 | 0 |
| 17:0 | 164 | 160 | 128 | 17:0 | 426 | 406 | 296 |
| 18:0 | 9449 | 226 | 156 | 18:0 | 9435 | 156 | 94 |
| 22:0 | 9451 | 1 | 0 | 22:0 | 9458 | 3 | 0 |
| 23:0 | 2472 | 1 | 0 | 23:0 | 9483 | 1 | 0 |
| 24:0 | 9569 | 0 | 0 | 24:0 | 9561 | 0 | 0 |
| Monounsaturated Fatty Acids | |||||||
| MUFA | 1 | 1 | 1 | MUFA | 0 | 0 | 0 |
| 14:1 | 3 | 3 | 0 | 14:1 | 9512 | 0 | 0 |
| 16:1 | 9440 | 229 | 161 | 16:1 | 9511 | 43 | 27 |
| 17:1 | 265 | 261 | 215 | 17:1 | 326 | 315 | 241 |
| 18:1 cis-9 | 9528 | 0 | 0 | 18:1 cis-9 | 9567 | 0 | 0 |
| 18:1 cis-11 | 922 | 775 | 451 | 18:1 cis-11 | 3959 | 3145 | 1861 |
| 18:1 cis-12 | 1 | 0 | 0 | 18:1 cis-12 | 0 | 0 | 0 |
| 18:1 cis-13 | 9536 | 7 | 0 | 18:1 cis-13 | 9577 | 4 | 0 |
| 18:1, trans-6/9 | 2619 | 0 | 0 | 18:1, trans-6/9 | 9637 | 0 | 0 |
| 18:1, trans-10/11 | 2918 | 2594 | 1925 | 18:1, trans-10/11 | 1924 | 1466 | 933 |
| 18:1, trans-12 | 0 | 0 | 0 | 18:1, trans-12 | - | - | - |
| 18:1, trans-15 | 54 | 36 | 26 | 18:1, trans-15 | 301 | 266 | 180 |
| Polyunsaturated Fatty Acids | |||||||
| PUFA | 9574 | 0 | 0 | PUFA | 9586 | 0 | 0 |
| 18:2 | 1 | 0 | 0 | 18:2 | 1 | 0 | 0 |
| 18:3, n-3 | 9723 | 0 | 0 | 18:3, n-3 | 9622 | 0 | 0 |
| 20:2 | 9442 | 2 | 2 | 20:2 | 9459 | 0 | 0 |
| 20:4 | 9455 | 0 | 0 | 20:4 | 9489 | 0 | 0 |
| 20:5 | 9625 | 0 | 0 | 20:5 | 9634 | 0 | 0 |
| 22:6 | 9499 | 0 | 0 | 22:6 | 9546 | 1 | 0 |
| CLA cis-9 trans-11 | 9559 | 0 | 0 | CLA cis-9 trans-11 | 9536 | 0 | 0 |
| CLA trans-10 cis-12 | 53 | 17 | 13 | CLA trans-10 cis-12 | 2853 | 90 | 52 |
| n-3 | 9555 | 0 | 0 | n-3 | 9588 | 0 | 0 |
| n-6 | 9433 | 94 | 58 | n-6 | 9431 | 155 | 91 |
| Ratio/Calculation | |||||||
| n-6:n-3 | 9556 | 2 | 2 | n-6:n-3 | 9601 | 2 | 2 |
| PUFASFA | 9575 | 0 | 0 | PUFASFA | 9585 | 0 | 0 |
| MCFA | 8793 | 337 | 189 | MCFA | 8628 | 461 | 244 |
| LCFA | 8771 | 341 | 188 | LCFA | 8596 | 460 | 244 |
| IAa | 12 | 4 | 1 | IAa | 3 | 0 | 0 |
| Total | 212824 | 6181 | 4211 | Total | 231227 | 7168 | 4401 |
aIA: Index of Atherogenicity
Number of significant identified epistatic interactions are displayed from left to right as filtered by FDR < 0.05, 50-animals per genotype combination with FDR < 0.05, and 100-animals per genotype combination with FDR < 0.05 for each fatty acid trait analyzed in both the Triacylclyceride and Phospholipid fatty acid fraction. This sum of the total significant interactions at each of these filters is then provided at the bottom of the table
Fig. 1Number of Animals in Lowest Genotype Combination by Interaction Count in TAG Fatty Acids. Histograms of number of animals found in the smallest genotype combination for each TAG interaction against the frequency of their occurrence. All sections left of a given animal cut off represent the number of interactions that would have been detected
Fig. 2Number of Animals in Lowest Genotype Combination by Interaction Count in PL Fatty Acids. Histograms of number of animals found in the smallest genotype combination for each PL interaction against the frequency of their occurrence. All sections left of a given animal cut off representing the number of interactions that would have been detected
Significant interactions by epistatic type at 50-animals per genotype combination
| Triacylglycerol Fatty Acids | Phospholipid Fatty Acids | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Trait | AA | AD | DD | Total Interactions | Trait | AA | AD | DD | Total Interactions |
| Saturated Fatty Acids | |||||||||
| SFA | 226 | 23 | 0 | 249 | SFA | 131 | 16 | 1 | 148 |
| 12:0 | 6 | 0 | 0 | 6 | 12:0 | 34 | 5 | 0 | 39 |
| 14:0 | 817 | 16 | 2 | 835 | 14:0 | 7 | 0 | 0 | 7 |
| 16:0 | 0 | 0 | 0 | 0 | 16:0 | 0 | 0 | 0 | 0 |
| 17:0 | 158 | 2 | 0 | 160 | 17:0 | 399 | 7 | 0 | 406 |
| 18:0 | 223 | 3 | 0 | 226 | 18:0 | 155 | 1 | 0 | 156 |
| 22:0 | 0 | 1 | 0 | 1 | 22:0 | 2 | 1 | 0 | 3 |
| 23:0 | 0 | 1 | 0 | 1 | 23:0 | 0 | 1 | 0 | 1 |
| 24:0 | 0 | 0 | 0 | 0 | 24:0 | 0 | 0 | 0 | 0 |
| Monounsaturated Fatty Acids | |||||||||
| MUFA | 1 | 0 | 0 | 1 | MUFA | 0 | 0 | 0 | 0 |
| 14:1 | 3 | 0 | 0 | 3 | 14:1 | 0 | 0 | 0 | 0 |
| 16:1 | 224 | 5 | 0 | 229 | 16:1 | 43 | 0 | 0 | 43 |
| 17:1 | 260 | 1 | 0 | 261 | 17:1 | 313 | 2 | 0 | 315 |
| 18:1 cis-9 | 0 | 0 | 0 | 0 | 18:1 cis-9 | 0 | 0 | 0 | 0 |
| 18:1 cis-11 | 769 | 6 | 0 | 775 | 18:1 cis-11 | 3110 | 35 | 0 | 3145 |
| 18:1 cis-12 | 0 | 0 | 0 | 0 | 18:1 cis-12 | 0 | 0 | 0 | 0 |
| 18:1 cis-13 | 7 | 0 | 0 | 7 | 18:1 cis-13 | 4 | 0 | 0 | 4 |
| 18:1, trans-6/9 | 0 | 0 | 0 | 0 | 18:1, trans-6/9 | 0 | 0 | 0 | 0 |
| 18:1, trans-10/11 | 2569 | 23 | 2 | 2594 | 18:1, trans-10/11 | 1449 | 17 | 0 | 1466 |
| 18:1, trans-12 | 0 | 0 | 0 | 0 | 18:1, trans-12 | - | - | - | - |
| 18:1, trans-15 | 36 | 0 | 0 | 36 | 18:1, trans-15 | 265 | 1 | 0 | 266 |
| Polyunsaturated Fatty Acids | |||||||||
| PUFA | 0 | 0 | 0 | 0 | PUFA | 0 | 0 | 0 | 0 |
| 18:2 | 0 | 0 | 0 | 0 | 18:2 | 0 | 0 | 0 | 0 |
| 18:3, n-3 | 0 | 0 | 0 | 0 | 18:3, n-3 | 0 | 0 | 0 | 0 |
| 20:2 | 2 | 0 | 0 | 2 | 20:2 | 0 | 0 | 0 | 0 |
| 20:4 | 0 | 0 | 0 | 0 | 20:4 | 0 | 0 | 0 | 0 |
| 20:5 | 0 | 0 | 0 | 0 | 20:5 | 0 | 0 | 0 | 0 |
| 22:6 | 0 | 0 | 0 | 0 | 22:6 | 1 | 0 | 0 | 1 |
| CLA cis-9 trans-11 | 0 | 0 | 0 | 0 | CLA cis-9 trans-11 | 0 | 0 | 0 | 0 |
| CLA trans-10 cis-12 | 15 | 2 | 0 | 17 | CLA trans-10 cis-12 | 73 | 17 | 0 | 90 |
| n-3 | 0 | 0 | 0 | 0 | n-3 | 0 | 0 | 0 | 0 |
| n-6 | 92 | 2 | 0 | 94 | n-6 | 150 | 5 | 0 | 155 |
| Ratio/Calculation | |||||||||
| n-6:n-3 | 2 | 0 | 0 | 2 | n-6:n-3 | 2 | 0 | 0 | 2 |
| PUFASFA | 0 | 0 | 0 | 0 | PUFASFA | 0 | 0 | 0 | 0 |
| MCFA | 336 | 1 | 0 | 337 | MCFA | 460 | 1 | 0 | 461 |
| LCFA | 340 | 1 | 0 | 341 | LCFA | 459 | 1 | 0 | 460 |
| IAa | 4 | 0 | 0 | 4 | IAa | 0 | 0 | 0 | 0 |
| Total | 6090 | 87 | 4 | 6181 | Total | 7057 | 110 | 1 | 7168 |
aIA: Index of Atherogenicity
Number of Additive-by-Additive (AA), Additive-by-Dominance and Dominance-by-Additive (AD), Dominance-by-Dominance (DD) significant epistatic interactions by type for Triacylclyceride and Phospholipid fatty acid traits by trait category (Saturated Fatty Acid [SFA], Monounsaturated Fatty Acid [MUFA], Polyunsaturated Fatty Acid [PUFA], Ratio/Calculation). All interactions are post FDR <5 % correction
Fig. 3Epistatic interactions plotted for PL fatty acid 16:1 at 50-animals per genotype. 265 total interactions plotted. Black lines: Additive x Additive interactions. Red lines: Additive x Dominance interactions. Blue lines: Dominance x Dominance interactions. Chromosomes ordered around outside with distance ticks every 12.5 MB. Black marks represent previously discovered 1 MB regions accounting for large amounts of additive variance
Significant interactions by epistatic type at 50-animals per genotype combination
| Trait | AA | AD | DD | Total Interactions |
|---|---|---|---|---|
| Weight Traits | ||||
| WW | 1 | 0 | 0 | 1 |
| YW | 2 | 1 | 0 | 3 |
| HCW | 0 | 0 | 0 | 0 |
| Total | 3 | 1 | 0 | 4 |
Number of Additive-by-Additive (AA), Additive-by-Dominance and Dominance-by-Additive (AD), Dominance-by-Dominance (DD) significant epistatic interactions by type for Weight traits Weaning Weight (WW), Yearling Weight (YW), and Hot Carcass Weight (HCW). All interactions are post FDR <5 % correction
Fig. 4Epistatic effect size frequency compared to individual SNP window effects. The frequency of epistatic genotype combination substitution effects by effect size is plotted for Epistatic interactions in TAG Fatty Acid 14:0. They are compared to the three largest individual SNP window effects for Fatty Acid 14:0 with a minor/major allele frequency 0.4/0.6 represented with vertical lines red (Chr:Mb start – 19:51), green (Chr:Mb start – 29:18), and blue (Chr:Mb – 10:19) identified in Saatchi et al. [6]
Fig. 5Number of Significant Epistatic Interactions identified with a random proportion of total animals. The proportion of animals out of the total number of animals was randomized each time, and was done at 50, 60, 70, 80, 90, 91–100 %. This analysis was performed using the TAG 18:1c11 fatty acid trait. Filters used: FDR (<0.05), 5 animals per genotype combination; points represent number of interactions detected at a given proportion of animals used